DrugPatentWatch Database Preview
Novast Labs Company Profile
What is the competitive landscape for NOVAST LABS, and what generic and branded alternatives to NOVAST LABS drugs are available?
NOVAST LABS has forty-two approved drugs.
There are three tentative approvals on NOVAST LABS drugs.
Summary for Novast Labs
| US Patents: | 0 |
| Tradenames: | 41 |
| Ingredients: | 28 |
| NDAs: | 42 |
Drugs and US Patents for Novast Labs
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novast Labs | LARIN 1.5/30 | ethinyl estradiol; norethindrone acetate | TABLET;ORAL-21 | 202996-001 | Mar 20, 2014 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Novast Labs | HER STYLE | levonorgestrel | TABLET;ORAL | 207976-001 | Mar 11, 2016 | OTC | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Novast Labs | INDOMETHACIN | indomethacin | CAPSULE, EXTENDED RELEASE;ORAL | 204853-001 | May 8, 2017 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Novast Labs | QUETIAPINE FUMARATE | quetiapine fumarate | TABLET, EXTENDED RELEASE;ORAL | 208947-004 | Nov 29, 2017 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Novast Labs | PRIMAQUINE PHOSPHATE | primaquine phosphate | TABLET;ORAL | 206043-001 | Jun 23, 2016 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
